9 March, 2017 by The TZ Newswire Staff Comments Off on OPEC Panics, Warns US Shale Not To "Assume" Production Cut Extension
OPEC Panics, Warns US Shale Not To "Assume" Production Cut Extension
All it took for OPEC to panic, was the sharpest drop in oil prices since last summer, sending WTI not only back under $50, but also wiping out all gains since the November Vienna “supply cut” deal.
9 March, 2017 by The TZ Newswire Staff Comments Off on Mark Cross and Chelsea Leyland collaborate on two bags to benefit epilepsy
Mark Cross and Chelsea Leyland collaborate on two bags to benefit epilepsy
Mark Cross and Chelsea Leyland have collaborated to create two bags that benefit a cause near and dear to Chelsea’s heart. Since she and her sister both suffer from epilepsy, and as she’s always been a fan of Mark Cross, this partnership to benefit Epilepsy Society seems only natural.
9 March, 2017 by The TZ Newswire Staff Comments Off on No matador in sight as bull market in U.S. stocks turns eight
No matador in sight as bull market in U.S. stocks turns eight
The run of gains on the financial market turns 8 years old on Thursday and, despite its advanced age, is expected to rage on, with perhaps a few hiccups, based on a combination of stronger company earnings, lower taxes and a corporate-friendly administration in Washington.
9 March, 2017 by The TZ Newswire Staff Comments Off on Higher yields drive dollar to three-week high vs. yen
Higher yields drive dollar to three-week high vs. yen
The dollar hit a three-week high against the yen on Thursday, on course for a fourth straight day of gains after a strong ADP job number in the previous session broke 10-year U.S. government bond yields out of a long-held range.
9 March, 2017 by The TZ Newswire Staff Comments Off on Why Ionis Pharmaceuticals Rallied 12% in February
Why Ionis Pharmaceuticals Rallied 12% in February
After reporting better-than-expected results in the fourth quarter and providing investors with an update on its R&D progress, shares in Ionis Pharmaceuticals (NASDAQ: IONS) increased more than 12% last month, according to S&P Global Market Intelligence.
9 March, 2017 by The TZ Newswire Staff Comments Off on Why Immunomedics, Inc. Jumped Higher Today
Why Immunomedics, Inc. Jumped Higher Today
Immunomedics (NASDAQ: IMMU) ended the day up 19.5% after a judge ruled that the biotech can’t close its deal with Seattle Genetics (NASDAQ: SGEN) quite yet.
The stock price going up after the deal was temporarily blocked may seem counterintuitive considering the deal for IMMU-132 was pretty solid, with Immunomedics getting $250 million upfront plus other milestone payments that could make the deal worth about $2 billion. And Seattle Genetics is also on the hook for royalty payments if the drug is eventually approved.
9 March, 2017 by The TZ Newswire Staff Comments Off on Why Marathon Oil, Signet Jewelers, and Immunomedics Jumped Today
Why Marathon Oil, Signet Jewelers, and Immunomedics Jumped Today
Thursday marked the eighth anniversary of the beginning of the current bull market in stocks. Back in 2009, investors thought that the financial crisis might result in the end of financial markets worldwide, but instead, stocks bounced back, and major market benchmarks have since tripled or more from their lows. Today, investors celebrated the market milestone in a relatively calm way, with only minor moves from popular indexes.